What is the data for the efficacy of vilazodone for major depressive disorder? Two phase III, 8-week, double-blind, placebo-controlled RCTs (Rickels et al, Khan et al) showed the efficacy of vilazodone for major depressive disorder. Methodological Tip: Phase III studies are the large randomized controlled trials that are done before a drug is approved by…
This content is for Monthly Membership and Yearly Membership members only.
Register
Register
Already a member? Log in here